CI
🔒 LOCKEDThe Cigna Group
🔒 Unlock Full Analysis
Sign in and use 1 credit to see AI verdict, intrinsic value, SWOT analysis, and all premium insights.
AI Executive Summary
The Cigna Group is a leading health services company with a diversified business model, currently undervalued based on its earnings and growth potential, but facing some near-term headwinds.
The Business DNA
The Cigna Group operates through two main segments: Evernorth Health Services and Cigna Healthcare. Evernorth provides pharmacy benefits and care delivery solutions, while Cigna Healthcare offers medical, pharmacy, and other related services. Cigna's diversified business model provides stability and growth opportunities. The company faces competition from other large healthcare providers and pharmacy benefit managers.
Financial Health
Valuation Analysis
Cigna's current price appears undervalued based on its PE ratio and forward PE. The target mean price suggests significant upside potential. The price-to-sales and price-to-book ratios also indicate a reasonable valuation. A discounted cash flow analysis supports an intrinsic value higher than the current market price.
Risks & Catalysts
Final Verdict: 🔒 LOCKED
Want More AI-Powered Analysis?
Get unlimited stock analyses, portfolio tracking, and real-time alerts
Related Stock Analyses
This analysis is generated by AI and should not be considered financial advice. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Last updated: 3/16/2026